A precision-based therapeutic approach that tailors cancer therapy according to the unique biological characteristics of each patient and their disease.

Custom Designed
Genomic Analysis
Treatment Efficacy
Recognize tumor-associated or tumor-specific antigens that are invisible to standard therapies.
Trigger immune response independently of conventional antigen-presenting pathways (MHC-independent).
Proliferate and persist within the patient’s body, offering potentially life-long surveillance.
Treatment is custom-designed for each patient based on their specific tumor biology.
Improved specificity significantly reduces damage to healthy tissues compared to radiation.
Harnesses the body’s own immune system as a living therapy that can adapt over time.
Careful patient selection and close monitoring for immune-related adverse events are standard. A multidisciplinary medical team ensures treatment safety, efficacy, and optimal patient outcomes from collection to infusion.